Medtronic's SuperDimension Franchise Acquires New Tool

Wednesday, July 15, 2015

Source: FierceMedicalDevices

Medtronic ($MDT) just launched the GenCut Core Biopsy system to collect lung cancer tissue from lesions deep inside the organ. The company says its blade design allows the device to collect larger and more intact samples, allowing enhanced pathology and cytology (microscopic imaging of cancerous cells), and ultimately improvements in personalized medicine of lung cancer.

View All News »